Eric R Braverman
Overview
Explore the profile of Eric R Braverman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
103
Citations
1671
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Blum K, Mclaughlin T, Lewandrowski K, Sharafshah A, Dennen C, Thanos P, et al.
J Addict Psychiatry
. 2025 Feb;
8(1):95-157.
PMID: 39949994
Background: The present study relates to a method to treat and detoxify patients with substance use disorder (SUD) utilizing a series of nicotinamide adenine dinucleotide (NAD+) and enkephalinase infusions (NADASE)...
2.
Sharafshah A, Lewandrowski K, Gold M, Fuehrlein B, Ashford J, Thanos P, et al.
Curr Neuropharmacol
. 2025 Jan;
PMID: 39865816
Introduction: Glucagon-Like Peptide-1 Receptor (GLP1R) agonists have become widespread anti-obesity/diabetes pharmaceuticals in the United States. Aim: This article aimed to provide our current knowledge on the plausible mechanisms linked to...
3.
Zeine F, Jafari N, Baron D, Bowirrat A, Pinhasov A, Norling B, et al.
J Addict Psychiatry
. 2024 Dec;
8(1):50-95.
PMID: 39635461
Objectives: The opioid crisis in the last few decades has mounted to a global level, impacting all areas of socioeconomic, demographic, geographic, and cultural boundaries. Traditional treatments have not been...
4.
Modestino E, Bowirrat A, Baron D, Thanos P, Hanna C, Bagchi D, et al.
J Addict Psychiatry
. 2024 Dec;
8(1):34-49.
PMID: 39618491
Reward deficiency syndrome (RDS) is an umbrella term encompassing a wide array of addictive behaviors that affect individuals across diverse spectra of society. Our research group has conducted a plethora...
5.
Blum K, Elman I, Han D, Hanna C, Baron D, Gupta A, et al.
Open J Immunol
. 2024 Nov;
14(3):60-86.
PMID: 39507617
Pediatric autoimmune neuropsychiatric disorders associated with or without streptococcal and other bacterial infections (PANDAS/CANS) are emerging as a featured pediatric disorder. Although there is some controversy regarding treatment approaches, especially...
6.
Blum K, Bowirrat A, Baron D, Elman I, Makale M, Cadet J, et al.
Gene Protein Dis
. 2024 May;
3(1).
PMID: 38766604
The D2 dopamine receptor () gene has garnered substantial attention as one of the most extensively studied genes across various neuropsychiatric disorders. Since its initial association with severe alcoholism in...
7.
Blum K, Braverman E, Gold M, Dennen C, Baron D, Thanos P, et al.
INNOSC Theranostics Pharmacol Sci
. 2024 May;
7(2):1472.
PMID: 38766548
The Carter Center has estimated that the addiction crisis in the United States (US), if continues to worsen at the same rate, may cost the country approximately 16 trillion dollars...
8.
Blum K, Baron D, Mclaughlin T, Thanos P, Dennen C, Ceccanti M, et al.
J Addict Psychiatry
. 2024 May;
8(1):1-33.
PMID: 38765881
Annotated bibliography of genetic addiction risk severity (GARS) publications, pro-dopamine regulation in nutraceuticals (KB220 nutraceutical variants), and policy documents. Further research is required to encourage the field to consider "Reward...
9.
Blum K, Bowirrat A, Thanos P, Hanna C, Khalsa J, Baron D, et al.
EC Psychol Psychiatr
. 2024 Feb;
13(1):1-3.
PMID: 38298272
No abstract available.
10.
Blum K, Mclaughlin T, Gold M, Gondre-Lewis M, Thanos P, Elman I, et al.
J Addict Psychiatry
. 2024 Jan;
7(1):5-516.
PMID: 38164471
In the USA alone, opioid use disorder (OUD) affects approximately 27 million people. While the number of prescriptions may be declining due to increased CDC guidance and prescriber education, fatalities...